Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N6022 in mild asthma
NCT01316315Phase 2Completed
- Sponsor
- Nivalis Therapeutics
- Start
- Mar 2011
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of N6022 in asthma, sponsored by Nivalis Therapeutics. Started Mar 2011; status: completed.
02
Drugs
N6022
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01316315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01316315.